Industries
remedē system receives approval for commercial use
Respicardia has announced that the first U.S. commercial case using the remedē System to treat central sleep apnea was completed at The Ohio State University Wexner Medical Center in Columbus, Ohio by Ralph Augostini, MD, FACC, FHRS, Bob and Corrine Frick Chair in Cardiac Electrophysiology, Associate Professor of Medicine and co-director of the electrophysiology training program.
3D printing living cells into biomedical objects
Using a new technique they call ‘in-air microfluidics’, University of Twente scientists succeed in printing 3D structures with living cells. This special technique enable the fast and ‘on-the-fly’ production of micro building blocks that are viable and can be used for repairing damaged tissue, for example. The work is presented in Science Advances. Microfluidics is all about manipulating tiny drops of fluid with ...
Strategies of multidrug-resistant chronic infections
A new study published in Cell Press finds that antibiotic treatment of chronic infections can be optimised by targeting vulnerabilities of antibiotic-resistant pathogens paving the way for more effective treatment strategies. Antibiotic-resistant Pseudomonas infections in cystic fibrosis patients show predictable sensitivities to other classes of antibiotics.
Stockholm station gets new platform screen doors control system
Within the Stockholm City and Stockholm Odenplan stations, the COPPILOT platform screen doors control system is designed by Clearsy, and it is now in charge of opening and closing the platform edge doors manufactured by Gilgen Door Systems. Originally opened back in July 2017, the Stockholm City and Stockholm Odenplan stations are the two stations of the Citybanan, a commuter railway tunnel beneath central Stockholm. For these two stations, ...
Automation: a guide to common applications
In its latest white paper, An Introduction to Common Collaborative Robot (cobot) Applications, Universal Robots provides an overview of how the technology can be easily integrated into common industrial applications to improve manufacturing processes. The six featured in this publication are pick and place; machine tending; packaging and palletizing; processing tasks - gluing, dispensing or welding; finishing tasks – polishing, grindin...
Cancer vaccine eliminates tumours in mice
Injecting minute amounts of two immune-stimulating agents directly into solid tumours in mice can eliminate all traces of cancer in the animals, including distant, untreated metastases, according to a study by researchers at the Stanford University School of Medicine. The approach works for many different types of cancers, including those that arise spontaneously, the study found.
Intravenous delivery system for treprostinil
Current guidelines in the United States and Europe recommend treatment with parenteral prostanoids for severe or rapidly progressing pulmonary arterial hypertension (PAH).2-4 However, risks and complexities associated with the current intravenous (IV) and subcutaneous (SC) delivery systems limit the acceptance of parenteral therapy. IV delivery via an indwelling central venous catheter is associated with the risk of serious bloodstream infections...
Tiny scales could help reinforce bones and joints
Scales are the material of choice for animals from pangolins to fish: They’re customisable, water-friendly, strong but flexible, and easy to fix when damaged. Scientists would like to recreate this unique structure—they can imagine uses from medical implants to flexible electronics—but it’s proved difficult using non-organic materials. But researchers with the University of Chicago have published a concept to use a na...
The effects of anti-cancer drug in human cells
Researchers at the Institute of Industrial Science (IIS), the University of Tokyo, CNRS and INSERM, report a new organ-on-a-chip technology for the study of blood vessel formation and drugs targeting this event. The technology recreates a human blood vessel and shows how new capillaries grow from a single vessel (parent vessel) in response to proper biochemical signaling cues.
Target genes to halt progression of thyroid cancer
Thyroid cancer is a disease with good cure rates in most cases. In 5% of patients, however, the tumour becomes refractory to the available therapies and may spread all over the body, causing death.